Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?

American Journal of Kidney Diseases

Volumn 41, Issue 6, 2003, Pages 1163-1169

  Gulati, Sanjeev ^a   Godbole, Madan ^b   Singh, Uttam ^b   Gulati, Kiran ^b   Srivastava, Arvind ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE

Author keywords

Bone mineral density (BMD); Nephrotic syndrome (NS); Osteoporosis

Indexed keywords

PREDNISONE;

ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CALCIUM INTAKE; CHILD; CLINICAL FEATURE; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EVALUATION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOCALCEMIA; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; MULTIVARIATE ANALYSIS; NEPHROTIC SYNDROME; ONSET AGE; OSTEOPOROSIS; PREDICTION; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RELAPSE; RISK FACTOR; SYMPTOM;

EID: 0038777401     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00348-2     Document Type: Article

References (28)

1. Chesney RW, Mazess RB, Rose P, Jax DK: Effect of prednisone on growth and bone mineral content in childhood glomerular diseases. Am J Dis Child 132:768-772, 1978
2. Freundlich M, Bourgoignie JJ, Zilleruelo G, Jacob Al, Cantebury JM, Strauss J: Bone modulating factors in nephrotic children with normal glomerular filtration rate. Pediatrics 76:280-285, 1985
3. Mittal SK, Dash S, Tiwari SC, Agarwal SK, Saxena S, Fisbane S: Bone histology in patients with nephrotic syndrome and normal renal function. Kidney Int 55:1912-1919, 1999
4. Freundlich M, Bourgoignie J, Zilleruelo G, Abitbol C, Cantebury JM, Strauss J: Calcium and vitamin D metabolism in children with nephrotic syndrome. J Pediatr 108:383-387, 1986
5. Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R: Vitamin D metabolites in children with nephrotic syndrome. Paediatr Nephrol 9:278-281, 1995
6. Cunnane G, Lane NE: Steroid induced osteoporosis in systemic lupus erythematosus. Rheum Dis North Am 26:311-329, 2000
7. Pitt P, Todd P, Webber D, Pack S, Moniz C: A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment. Thorax 53:351-356, 1998
8. Sambrook PN: Inhaled corticosteroids, bone density, and risk of fracture. Lancet 355:1385, 2000
9. Gulati S, Kher V, Elhence R, Kumar P, Sharma RK, Gupta A: Treatment of nephrotic syndrome. Ind Pediatr 31:165-170, 1994
10. Olgaard K, Storm T, Van Wovern N, et al: Glucorticoid induced osteoporosis in lumbar spine, forearm and mandible of nephrotic patients: A double blind study on high dose long term effects of prednisolone versus deflazocort. Calcif Tissue Int 50:460-467, 1992
11. Lettgen G, Jeken C, Reiners C: Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 8:667-670, 1994
12. Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H: Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high dose glucocorticoid and one cycle etidronate therapy. Calcif Tissue Int 66:195-199, 2000
13. Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M: Bone mineral content in children on long term alternate day prednisolone. Clin Pediatr 34:234-236, 1995
14. Mehls O: Is it correct to supplement patients with nephrotic syndrome with vitamin D and calcium? Pediatr Nephrol 4:519, 1990
15. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571-590, 1987
16. Gulati S, Kher V, Sharma RK, Gupta A: Steroid response pattern in Indian children with nephrotic syndrome. Acta Pediatr Scand 83:530-533, 1994
17. Elhence R, Gulati S, Kher V, Sharma RK, Gupta A: Intravenous pulse cyclophosphamide - A new regime for steroid resistant minimal change nephrotic syndrome. Pediatr Nephrol 8:1-3, 1994
18. Gulati S, Pokharial S, Elhence R, Sharma RK, Kher V, Gupta A: Pulse cyclophosphamide therapy in frequent relapsing nephrotic syndrome. Nephrol Dial Transplant 16: 2013-2017, 2001
19. Southard RN, Douglas MJ, Mahan JD, et al: Bone mass in healthy children - Measurement with quantitative DXA. Radiology 179:735-738, 1991
20. Miler PD, Bonnick SL, Rosen CJ, et al: Clinical utility of bone mass measurement in adults: Consensus of an international panel - The Society of Clinical Densitometry. Semin Arthritis Rheum 25:361-372, 1996
21. American College of Rheumatology Task Force on Osteoporosis: Recommendations for the prevention and treatment of osteoporosis guidelines. Arthritis Rheum 39:1791-1801, 1996
22. Mizokuchi M, Kubota M, Tomino Y, Koide H: Possible mechanism of impaired calcium and vitamin D metabolism in nephrotic rats. Kidney Int 42:335-340, 1992
23. Chan YL, Mason RS, Parmentier M, Savdie E, Lissner D, Posen S: Vitamin D metabolism in nephrotic rats. Kidney Int 24:336-341, 1983
24. Jehle MJ, Jehle DR: Use of corticosteroids in nephrology - Risk and prevention of osteoporosis induction. Nephrol Dial Transplant 15:565-568, 2000
25. Stevenson JC: Management of corticosteroid induced osteoporosis. Lancet 352:1327-1328, 1998
26. Dempster DW: Bone histomorphometry in glucocorticoid induced osteoporosis. J Bone Miner Res 4:137-141, 1989
27. Morin D, Kotzki PO, Dalla Vale P, Rossi M, Dumas R: Bone mineral density in children with steroid sensitive nephrotic syndrome. Pediatr Nephrol 10:C147A, 1996 (abstr)
28. Buckley LM, Leib ES, Cartularo KS, et al: Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 125:961-968, 1996